Drug Type Small molecule drug |
Synonyms celtisine |
Target |
Action modulators |
Mechanism DRDs modulators(Dopamine receptors modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19NO4 |
InChIKeyVRFVDWALYCNYTM-LBPRGKRZSA-N |
CAS Registry91106-25-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | United States | 22 Jul 2024 |